Compass Therapeutics, Inc. (CMPX)
0.993
+0.01
(+0.98%)
USD |
NASDAQ |
Oct 09, 16:00
0.9912
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Cash from Operations (Quarterly) : -14.74M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.74M |
| March 31, 2026 | -17.27M |
| December 31, 2025 | -13.25M |
| September 30, 2025 | -10.85M |
| June 30, 2025 | -11.83M |
| March 31, 2025 | -13.21M |
| December 31, 2024 | -9.162M |
| September 30, 2024 | -11.05M |
| June 30, 2024 | -10.75M |
| March 31, 2024 | -13.89M |
| December 31, 2023 | -12.35M |
| September 30, 2023 | -5.922M |
| June 30, 2023 | -10.11M |
| March 31, 2023 | -12.23M |
| December 31, 2022 | -10.64M |
| Date | Value |
|---|---|
| September 30, 2022 | -10.94M |
| June 30, 2022 | -4.60M |
| March 31, 2022 | -7.942M |
| December 31, 2021 | -4.665M |
| September 30, 2021 | -3.457M |
| June 30, 2021 | -5.939M |
| March 31, 2021 | -5.605M |
| December 31, 2020 | -6.573M |
| September 30, 2020 | -7.169M |
| June 30, 2020 | -5.30M |
| March 31, 2020 | -7.761M |
| December 31, 2019 | -5.591M |
| September 30, 2019 | -6.704M |
| June 30, 2019 | -8.969M |
| March 31, 2019 | -10.48M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -125.17M |
| Capricor Therapeutics, Inc. | -31.49M |
| Ardelyx, Inc. | -6.399M |
| Biomea Fusion, Inc. | -10.03M |
| ARS Pharmaceuticals, Inc. | -60.93M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -4.977M |
| Free Cash Flow | -56.38M |
| Free Cash Flow Per Share (Quarterly) | -0.0798 |
| Free Cash Flow to Equity (Quarterly) | -14.76M |
| Free Cash Flow to Firm (Quarterly) | -14.91M |
| Free Cash Flow Yield | -31.24% |